[ad_1] Coldrif case: ED attaches assets worth over Rs 2 crore of Sresan Pharma proprietor We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] 700 plus cough syrup makers under scrutiny after child deaths in MP: Anupriya Patel We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] India refuses drugmakers requests to extend deadline for plant upgradation We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] WHO issues alert over contaminated India cough syrups We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Tamil Nadu cancels licence of Sresan Pharma, orders shutdown We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] ED Raids Sresan Pharma We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Chennai: Tamil Nadu Drugs Control Department on Monday announced the cancellation of the manufacturing license of Sresan Pharmaceutical company, the manufacturer of Coldrif cough syrup, linked with deaths of at least 22 people in Madhya Pradesh. The state health department stated that the company has been officially shut down after its investigation of toxic…
[ad_1] Coldrif fallout: How a Pharma firm skipped India’s Drug Watchdog inspections We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Coldrif cough syrup banned in Delhi We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] SC to hear plea seeking CBI probe into cough syrup deaths on October 10 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link